Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report
its fourth quarter and 2011 full year financial results on February 14,
2012, after close of market.
Fluidigm President and Chief Executive Officer Gajus Worthington, and
Chief Financial Officer Vikram Jog, will host a conference call at 2:00
p.m. PST (5:00 p.m. EST) on February 14, 2012, to discuss fourth quarter
and 2011 full year financial results and operating activities. A press
release outlining the financial results will be publicly distributed
prior to the call.
The Fluidigm conference call can be accessed by calling (877) 556-5248
(domestic toll-free) or (720) 545-0029 (international toll). There will
be a Q&A period during the call.
Fluidigm will also provide a live stream of its fourth quarter and 2011
full year financial results conference call for investors at: http://investors.fluidigm.com/events.cfm.
The link will not be active until 1:45 p.m. PST on February 14, 2012. A
telephone replay of the teleconference will be available 90 minutes
after the end of the call at (855) 859-2056 (domestic toll-free), or
(404) 537-3406 (international toll), access code 48648892. The
conference call will also be archived on the Fluidigm investor’s page
at: http://investors.fluidigm.com.
About Fluidigm
Fluidigm (NASDAQ:) develops, manufactures and markets microfluidic
systems for growth markets in the life science and agricultural
biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary
microfluidic systems consist of instruments and consumables, including
chips, assays and other reagents. These systems are designed to
significantly simplify experimental workflow, increase throughput and
reduce costs, while providing the excellent data quality demanded by
customers. Fluidigm actively markets three microfluidic systems,
including eight different commercial chips, to leading pharmaceutical
and biotechnology companies, academic institutions and Ag-Bio companies.
For more information, please visit .
Fluidigm and the Fluidigm logo, are trademarks or registered trademarks
of Fluidigm Corporation

Add GEN to your Inbox FREE!
Subscribe today to our complimentary e-Newsletters and stay abreast of the latest biotech news and trends.